OraSure to Announce First Quarter 2024 Financial Results and Host Earnings Call on May 8th

FacebookFacebookTwitterTwitterEmailEmailLinkedInLinkedInWhatsAppWhatsAppMessengerMessengerFlipboardFlipboardGmailGmailTelegramTelegramShareShare

BETHLEHEM, Pa., April 22, 2024 (GLOBE NEWSWIRE) — OraSure Technologies, Inc. (NASDAQ: OSUR) has scheduled its regular earnings conference call covering first quarter 2024 financial results and certain business developments for 4:45 p.m. ET on Wednesday, May 8, 2024.

A webcast of the conference call will be available on the investor relations page of OraSure’s website at https://orasure.gcs-web.com/events-and-presentations. Please click on the webcast link and follow the prompts for registration and access at least 10 minutes prior to the call. The webcast will be archived on OraSure’s website shortly after the call has ended and will be available for approximately 90 days.

To participate in the live conference call, please follow the link below to pre-register. After registering, you will be provided with access details via email.

https://register.vevent.com/register/BI6ea5c5c7630d4ba196be212024e8c2e6

About OraSure Technologies, Inc. 
OraSure Technologies (the “Company”) transforms health through actionable insight and powers the shift that connects people to healthcare wherever they are. The Company improves access, quality, and value of healthcare with innovation in effortless tests, sample management solutions, and services. OraSure, together with its wholly-owned subsidiaries, DNA Genotek, Diversigen, and Novosanis, provides its customers with end-to-end solutions that encompass diagnostics, tools, and services. The OraSure family of companies is a leader in the development, manufacture, and distribution of rapid diagnostic tests, sample collection and stabilization devices, and molecular services solutions designed to discover and detect critical medical conditions. OraSure’s portfolio of products is sold globally to clinical laboratories, hospitals, physician’s offices, clinics, public health and community-based organizations, research institutions, government agencies, pharmaceutical companies, commercial entities, and direct to consumers. For more information on OraSure Technologies, please visit www.orasure.com.

Investor Contact: Media Contact:
Jason Plagman Amy Koch
VP, Investor Relations Director, Corporate Communications
investorinfo@orasure.com media@orasure.com

Staff

Recent Posts

Aesthetic Partners Welcomes Healthcare Leader Mark Censoprano to Its Board Leadership Team

MIAMI, July 28, 2025 /PRNewswire/ -- Aesthetic Partners, a leading medical aesthetics and plastic surgery…

5 hours ago

IMV Announces Initial Winners of 2025 ServiceTrak™ Clinical Laboratory Awards, Honored at ADLM Annual Conference

ARLINGTON, Va., July 28, 2025 /PRNewswire/ -- IMV, part of the Science and Medicine Group…

5 hours ago

Trella Health Releases 2025 Post-Acute Care Industry Trend Report Highlighting Continued Medicare Advantage Growth and Shifts in Care Utilization

New annual report reveals national and state-level trends across home health, hospice, and skilled nursing.…

5 hours ago

$10 Million Philanthropic Donation Launches Research Effort into Root Causes of Stuttering

COSTA MESA, Calif., July 28, 2025 /PRNewswire/ -- The newly founded Stuttering Treatment and Research Society…

5 hours ago

CORRECTION FROM THE SOURCE: FloraWorks Highlights New Study Showing CBN Reverses Cognitive Decline in Aging Mice

Peer-reviewed research published in Redox Biology supports the therapeutic potential of Cannabinol (CBN) in brain…

10 hours ago